KR20050034713A - 비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법 - Google Patents

비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법 Download PDF

Info

Publication number
KR20050034713A
KR20050034713A KR1020057000506A KR20057000506A KR20050034713A KR 20050034713 A KR20050034713 A KR 20050034713A KR 1020057000506 A KR1020057000506 A KR 1020057000506A KR 20057000506 A KR20057000506 A KR 20057000506A KR 20050034713 A KR20050034713 A KR 20050034713A
Authority
KR
South Korea
Prior art keywords
hydrogen
tetracycline
cmt
antibacterial
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020057000506A
Other languages
English (en)
Korean (ko)
Inventor
브라운데이비드
골럽론엠.
리시-밍
그린왈드로버트에이.
Original Assignee
더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 filed Critical 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕
Publication of KR20050034713A publication Critical patent/KR20050034713A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020057000506A 2002-07-12 2003-07-11 비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법 Withdrawn KR20050034713A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39546602P 2002-07-12 2002-07-12
US60/395,466 2002-07-12

Publications (1)

Publication Number Publication Date
KR20050034713A true KR20050034713A (ko) 2005-04-14

Family

ID=30115878

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057000506A Withdrawn KR20050034713A (ko) 2002-07-12 2003-07-11 비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법

Country Status (8)

Country Link
US (1) US20050282786A1 (enExample)
EP (1) EP1531830A4 (enExample)
JP (1) JP2005533110A (enExample)
KR (1) KR20050034713A (enExample)
AU (1) AU2003256496A1 (enExample)
CA (1) CA2491655A1 (enExample)
NZ (1) NZ538198A (enExample)
WO (1) WO2004006938A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220020832A (ko) * 2019-06-14 2022-02-21 조슈아 오. 아티바 단백질 감염에 사용하기 위한 3원 약학 조성물

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004091483A2 (en) * 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
CN105010359B (zh) * 2015-06-24 2018-05-18 广东中迅农科股份有限公司 含有四霉素和氟环唑的杀菌组合物
CN104957154B (zh) * 2015-06-24 2018-05-18 广东中迅农科股份有限公司 含有四霉素和醚菌酯的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US5223248A (en) * 1991-02-11 1993-06-29 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing antiplaque properties
US5523297A (en) * 1993-03-02 1996-06-04 The Research Foundation Of State University Of New York Inhibition of excessive phospholipase A2 activity and/or production by non-antimicrobial tetracyclines
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
EP2332547A1 (en) * 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of inflammatory bowel disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220020832A (ko) * 2019-06-14 2022-02-21 조슈아 오. 아티바 단백질 감염에 사용하기 위한 3원 약학 조성물

Also Published As

Publication number Publication date
NZ538198A (en) 2006-11-30
US20050282786A1 (en) 2005-12-22
CA2491655A1 (en) 2004-01-22
EP1531830A1 (en) 2005-05-25
EP1531830A4 (en) 2007-09-05
AU2003256496A1 (en) 2004-02-02
JP2005533110A (ja) 2005-11-04
WO2004006938A1 (en) 2004-01-22

Similar Documents

Publication Publication Date Title
US6841547B2 (en) Method for decreasing low density lipoprotein
US5308839A (en) Composition comprising non-steroidal anti-inflammatory agent tenidap and effectively non-antibacterial tetracycline
CA2031368C (en) Composition comprising non-steroidal non-inflammatory agent and effectively non-antibacterial tetracycline
JP2676080B2 (ja) 非抗バクテリア性テトラサイクリン組成物
AU2002256092C1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
JP2011168613A (ja) ざ瘡の治療方法
US20080233151A1 (en) Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins
KR20050034713A (ko) 비-항균성 테트라사이클린 제형을 사용하여 ｃ-반응성단백질 수준을 감소시키는 방법
AU2005222937B2 (en) Method for treating aortic stenosis with non-antibacterial tetracycline formulations
WO2004054509A2 (en) Tetracyclines as anti-fungal agents for treatment of ringworm
IE911519A1 (en) A Novel Anti-Collagenolytic Formulation for the Treatment of¹Chronic Inflammatory Diseases
NZ522733A (en) Non-antibacterial tetracycline as anti-fungal agents

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050111

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid